A long term follow up study for a comparison of stepwise treatment of asthmatic children with salmeterol/fluticasone propionate combination product (Seretide) and/or fluticasone propionate (Flixotide) based on PD20 methacholine and symptoms or based on symptoms only ('Children Asthma Therapy Optimal')
Phase of Trial: Phase III
Latest Information Update: 16 Mar 2012
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Acronyms CATO
- Sponsors GlaxoSmithKline
- 16 Jun 2011 Actual end date (Oct 2007) added as reported by ClinicalTrials.gov.
- 07 Mar 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Apr 2007 New trial record.